The Rate of Diabetes Mellitus That Wasn't Previously Found in Patients With Acute Coronary Syndrome Using Hba1c

Objective: To determine the percentage of individuals with acute coronary syndrome (ACS) who have never been diagnosed with diabetes mellitus. Using HBA1c as parameter. Study Design: A Cross-sectional Study Place and duration of study: Department of Cardiology & Endocrinology HMC Hospital Peshawar from 1st Jan 2022 to 1st jan- 2022 Methods: Out of 100 patients diagnosed with ACS and hospitalized with acute chest discomfort, participants were chosen for the research. Following a comprehensive history and physical examination, these individuals had an ECG, serum troponin-I level, haemoglobin level, and HbA1C tests. The patient's BMI, age, gender, and HbAlc level were recorded. Each patient's outcome (diabetes, prediabetes, and non-diabetic) was recorded. Results: With a mean age of 52.07 years, 70% of the 100 participants were male. The HbA1c level was 4.11%±1.79% on average. STEMI (70.20%) was the most prevalent kind of ACS, followed by NSTEMI (22.81%). 8% of individuals had just received a diabetes mellitus diagnosis. According to statistical analysis, age, gender, or type of ACS did not significantly correlate with the diagnosis of diabetes mellitus. These results highlight the high rate of diabetes mellitus that goes undiagnosed in ACS patients, underscoring the need for early screening in this group. Conclusion: The study emphasizes the need for proactive DM screening in this group by highlighting a high incidence of previously undetected DM among ACS patients. In individuals with ACS, early identification and treatment of DM may reduce cardiovascular risks and enhance therapeutic results. To enable prompt diagnosis and management of diabetes mellitus, healthcare practitioners should include HbA1c testing in regular evaluations for patients with ACS. This would eventually lower the morbidity and death rates linked to cardiovascular problems.